Advanced search
Publication Cover
Future Cardiology Volume 4, 2008 - Issue 6
Submit an article Journal homepage
56
Views
0
CrossRef citations to date
0
Altmetric
Review

Natriuretic Peptides and Their Evolving Clinical Applications

Markus Noveanua University Hospital Basel Petersgraben 4Basel4031Switzerland. [email protected]
,
Mihael Potockib University Hospital Basel Petersgraben 4Basel4031Switzerland. [email protected]
&
Christian Muellerc Professor of Medicine University Hospital Basel Petersgraben 4Basel4031Switzerland. [email protected]
Pages 593-598 | Published online: 18 Nov 2008

Bibliography

  • Iwanaga Y , NishiI, FuruichiSet al.: B-type natriuretic peptide strongly refelects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.J. Am. Coll. Cardiol., 47, 742–748 (2006).
  • Choi EY , HaJW, JoungBet al.: Effects of hemoglobin concentration and creatinine clearance in pro-B-type natriuretic peptide-based left ventricular filling pressure prediction in patients with preserved left ventricular systolic function.Am. J. Cardiol., 101, 364–369 (2008).
  • Remes J , MiettinenH, ReunanenAet al.: Validity of clinical diagnosis of heart failure in primary health care.Eur. Heart J., 12, 315–321 (1991).
  • Cowie MR , StruthersAD, WoodDAet al.: Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care.Lancet, 350, 1349–1353 (1997).
  • Owan TE , HodgeDO, HergesRMet al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction.N. Engl. J. Med., 355, 251–259 (2006).
  • Maisel AS , KrishnaswamyP, NowakRMet al.: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N. Engl. J. Med., 347, 161–167 (2002).
  • Davis M , EspinerE, RichardsGet al.: Plasma brain natriuretic peptide in assessment of acute dyspnea.Lancet, 343, 440–444 (1994).
  • Lainchbury JG , CampbellE, FramptonCMet al.: Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.J. Am. Coll. Cardiol., 42, 728–735 (2003).
  • Januzzi JL , CamargoCA, AnwaruddinSet al.: The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.Am. J. Cardiol., 95, 948–954 (2005).
  • Wright SP , DoughtyRN, PearlAet al.: Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. A randomized, controlled trial.J. Am. Coll. Cardiol., 42, 1793–1800 (2003).
  • Maisel AS , CloptonP, KrishnaswamyPet al.: Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study.Am. Heart J., 147, 1078–1084 (2004).
  • Mueller C , Laule-KilianK, FranaBet al.: The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnea.J. Intern. Med., 258, 77–85 (2005).
  • Fonarow GC , PeacockWF, PhillipsCOet al.: Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure ADHERE Scientific Advisory Committee and Investigators.J. Am. Coll. Cardiol., 49, 1943–1950 (2007).
  • Christ M , Laule-KilianK, HochholzerWet al.: Gender-specific risk stratification using B-type natriuretic peptide levels in patients with acute dyspnea: insights from the BASEL study.J. Am. Coll. Cardiol., 48, 1808–1812 (2006).
  • Christ M , ThuerlimannA, LauleKet al.: Long-term prognostic value of B-type natriuretic peptide level in cardiac and non-cardiac causes of acute dyspnea.Eur. J. Clin. Invest., 37(11), 834–841 (2007).
  • Mueller C , ScholerA, Laule-KilianKet al.: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.N. Engl. J. Med., 350, 647–654 (2004).
  • Moe GW , HowlettJ, JanuzziJLet al.: N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study.Circulation, 115, 3103–3110 (2007).
  • Breidthardt T , LauleK, StrohmeyerAHet al.: Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea.Clin. Chem.1415–1422 (2007).
  • Mueller C , BreidthardtT, Laule-KilianK, ChristM, PerruchoudAP: The intergration of BNP and NT-proBNP into clinical medicine.Swiss Med. Wkly, 137, 4–12 (2007).
  • Januzzi JL et al. , van Rimmenade R, Lainchbury J : NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. The International Collaborative of NT-proBNP Study. Eur. Heart J., 27, 330–337 (2006).
  • Strunk A , BhallaV, CloptonPet al.: Impact of history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.Am. J. Med., 119 (69), E1–E11 (2006).
  • Knudsen CW , OmlandT, CloptonPet al.: Diagnostic value of B-type natriuretic peptide and chest radiographic findings in patients with acute dyspnea.Am. J. Med., 116, 363–368 (2004).
  • Mueller-Lenke N , RudezJ, staubDet al.: Use of chest radiography in the emergency diagnosis of acute congestive heart failure.Heart, 92, 695–696 (2006).
  • Studler U , KretschmarM, ChristMet al.: Accuracy of chest radiographs in the emergency diagnosis of heart failure.Eur. Radiol., 18, 1644–1652 (2008).
  • Arques S , RouxE, SbragiaPet al.: Usefulness of bedside tissue Doppler echocardiography and B-type natriuretic peptide (BNP) in differentiating congestive heart failure from noncardiac cause of acute dyspnea in elderly patients with a normal left ventricular ejection fraction and permanent, nonvalvular atrial fibrillation: insights from a prospective, monocenter study.Echocardiography, 24, 499–507 (2007).
  • Logeart D , ThabutG, JourdainPet al.: Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure.J. Am. Coll. Cardiol., 43, 635–641 (2004).
  • Anand IS , FisherLD, ChiangYTet al.: Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT).Circulation, 107, 1278–1283 (2003).
  • Bettencourt P , AzevedoA, PimentaJet al.: N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.Circulation, 110, 2168–2174 (2004).
  • Troughton RW , FramptonCM, YandleTGet al.: Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations.Lancet, 355, 1126–1130 (2000).
  • Jourdain P , JondeauG, FunckFet al.: Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study.J. Am. Coll. Cardiol.1733–1739 (2007).
  • Morrow DA et al. , de Lemos JA, Sabatine MS : Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J. Am. Coll. Cardiol., 41, 1264–1272 (2003).
  • Mueller CH : The use of B-type natriuretic peptides in coronary artery disease: utile or futile?J. Am. Coll. Cardiol., 50, 215–216 (2007).
  • Christ-Crain M , BreidthardtT, StolzDet al.: Use of B-type natriuretic peptide in the risk stratification of community-acquired pneumonia.J. Intern. Med., 264, 166–176 (2008).
  • McDonagh TA , RobbSD, MurdochDRet al.: Biochemical detection of left-ventricular systolic dysfunction.Lancet, 351, 9–13 (1998).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.